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Abstract
Parathyroid hormone-related protein (PTHrP) and hedgehog signaling play an important
role in chondrocyte development, (hypertrophic) differentiation, and/or calcification, but
their role in intervertebral disc (IVD) degeneration is unknown. Better understanding their
involvement may provide therapeutic clues for low back pain due to IVD degeneration.
Therefore, this study aimed to explore the role of PTHrP and hedgehog proteins in post-
natal canine and human IVDs during the aging/degenerative process. The expression of
PTHrP, hedgehog proteins and related receptors was studied during the natural loss of
the notochordal cell (NC) phenotype during IVD maturation using tissue samples and de-
differentiation in vitro and degeneration by real-time quantitative polymerase chain reac-
tion (RT-qPCR) and immunohistochemistry. Correlations between their expression and
calcification levels (Alizarin Red S staining) were determined. In addition, the effect of
PTHrP and hedgehog proteins on canine and human chondrocyte-like cells (CLCs) was
determined in vitro focusing on the propensity to induce calcification. The expression of
PTHrP, its receptor (PTHR1) and hedgehog receptors decreased during loss of the NC
phenotype. N-terminal (active) hedgehog (Indian hedgehog/Sonic hedgehog) protein
expression did not change during maturation or degeneration, whereas expression of
PTHrP, PTHR1 and hedgehog receptors increased during IVD degeneration. Hedgehog
and PTHR1 immunopositivity were increased in nucleus pulposus tissue with abundant vs
no/low calcification. In vitro, hedgehog proteins facilitated calcification in CLCs, whereas
PTHrP did not affect calcification levels. In conclusion, hedgehog and PTHrP expression is
present in healthy and degenerated IVDs. Hedgehog proteins had the propensity to
induce calcification in CLCs from degenerated IVDs, indicating that in the future, inhibiting
hedgehog signaling could be an approach to inhibit calcification during IVD degeneration.
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1 | INTRODUCTION
Over 80% of the human population experiences low back pain during
their lifetime.1 An important cause for low back pain is degeneration of
the intervertebral disc (IVD).2 The IVD consists of an inner gelatinous
nucleus pulposus (NP) and outer fibrous annulus fibrosus. During IVD
maturation, large, vacuolated notochordal cells (NCs) are replaced by
smaller, non-vacuolated chondrocyte-like cells (CLCs), a process that in
the human NP has come to near completion already at birth.3 Thus, a
“healthy” human NP from a child or young adult contains CLCs, and
often no NCs, implying that the NC transition towards a CLC cellular
phenotype is initially part of a maturation process. The healthy NP con-
tains a high glycosaminoglycan (GAG) content that attracts water,
whereas during IVD degeneration, the NP GAG and water content
decreases and denatured collagen content increases,4 resulting in NP
dehydration and more rigid extracellular matrix (ECM). The avascular
IVD exhibits inadequate repair, leading to a vicious circle: the IVD
weakens and is more vulnerable to damage by physiologic loading. Con-
sequently, loss of mechanical function, traumatic damage, and pain
develop.5 Current treatments for IVD disease are primarily aimed at
relieving symptoms. Therefore, there is an urgent need for agents stim-
ulating biological IVD repair.6 To develop such treatments, further
knowledge of the pathogenesis of IVD degeneration is required.
Numerous signaling pathways have been proposed to play a role
in IVD degeneration, including Wnt/β-catenin, Sonic hedgehog (SHH),
and hypoxia-inducible factor signaling.7–9 SHH and Indian hedgehog
(IHH) morphogens belong to the hedgehog family, which plays a cru-
cial role in embryonic development. Hedgehog proteins undergo intra-
molecular cleavage catalyzed by their C-terminal domain, yielding an
N-terminal product that represents the mature and biologically active
hedgehog form and a C-terminal product with no known signaling-
related function.10 SHH has been related to IVD formation and main-
tenance11 and based on this precedence, it is thought to be primarily
involved in (patho)physiology of the IVD. In contrast, IHH is consid-
ered to primarily have a biologic role at the growth plate and joint car-
tilage level.12 While the regulation of hedgehog signaling is well
described at the postnatal growth plate and to some extent at the
joint cartilage level, the role of these two hedgehogs in postnatal IVDs
of species that can suffer from clinical IVD disease remains largely
elusive.
At the growth plate level, IHH and PTHrP form a growth-
restraining feedback loop regulating chondrocyte differentiation dur-
ing endochondral ossification.13–15 IHH, produced by prehypertrophic
growth plate chondrocytes, promotes proliferation and differentiation,
and stimulates calcification independently from PTHrP.16 In the
absence of hedgehogs, their receptor: Patched (PTCH1) interacts with
transmembrane protein Smoothened (SMO), thereby inhibiting down-
stream hedgehog signaling. In the presence of hedgehog ligands,
PTCH1 interacts with the ligand and is internalized. Upon this, SMO
translocates to the cell membrane and activates downstream canoni-
cal hedgehog signaling, including activated target gene expression
through three GLI transcription factors. GLI1 functions as transcrip-
tional activator, whereas GLI2 and GLI3 act as either positive or
negative regulators, depending on posttranscriptional and transla-
tional processing.13,14,16–18 PTHrP, produced by periarticular cho-
ndrocytes, prevents proliferative cells from leaving the proliferating
growth plate zone. Moreover, targeted overexpression of PTHrP
delays the appearance of hypertrophic chondrocytes.19 When cho-
ndrocytes are no longer sufficiently stimulated by PTHrP, they stop
proliferating and synthesize IHH.20
Hedgehogs have been studied to some extent in joint cartilage
degeneration.21 Considering the high homology of the biologically
active N-terminus of IHH and SHH (ie, 88% at the amino acid level)
and the fact that these ligands share downstream signaling pathways,
the reported studies are not always able to discern which of the
hedgehog ligands are involved. A positive correlation between IHH or
SHH expression and osteoarthritis (OA) has been described.22–25 Fur-
thermore, activated hedgehog signaling aggravated the OA phenotype
in genetically modified mice.23 In line with this, disrupted (Indian)
hedgehog signaling prevented hypertrophic chondrocyte differentia-
tion and osteophyte formation in OA cartilage.26,27 Furthermore, SHH
may be involved in redifferentiation of transplanted chondrocytes, as
de-differentiated chondrocytes transfected with SHH showed
improved cartilage repair in a rat articular cartilage defect model.28
Notably, PTHR1 expression was decreased in OA chondrocytes29 and
PTHrP suppressed chondrocyte mineralization and hypertrophy,30
indicating that PTH(rP) signaling might prevent the development and
progression of OA.31
Previous work indicated that IVD degeneration resembles OA, for
example, hypertrophic differentiation and calcification are phenomena
that can occur in both tissues during degeneration.32 Although hedge-
hog and PTHrP are extensively studied in (OA) joint cartilage, limited
information is available regarding their role in the postnatal IVD. Pre-
vious work indicated that hedgehog9,33,34 and PTCH19,35 are
expressed in the postnatal murine IVD, whereas PTHrP was absent.9
PTH partially recovered NC numbers in the NPs of ovariectomized
rat36 and suppressed calcification in degenerated human CLCs.37
Thus, results from limited work conducted thus far imply that hedge-
hog proteins and PTHrP could potentially be targets for IVD repair. To
take this a step further, in the present study, the expression of PTHrP
and hedgehog proteins was determined in IVD maturation and degen-
eration by employing postnatal IVDs that can suffer from clinical IVD
disease. The setup of the study is presented in Figure 1, and a sche-
matic overview of the results is given in Table 1.
2 | MATERIALS AND METHODS
2.1 | Study design
In this study, hedgehog, PTHrP, and related receptor expression and
function were determined in two different phases: during the loss of
the NC phenotype (maturation phase) and in maturated until severely
degenerated IVDs (degeneration phase) (Figure 1). Canine tissues and
cells were employed considering the fact that they are readily avail-
able, and that dogs experience back pain and IVD degeneration with
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similar characteristics as humans and are a suitable translational animal
model.38–40 Dog breeds can be classified as chondrodystrophic (CD) or
non-chondrodystrophic (NCD).41 CD and NCD dogs demonstrate dis-
tinct differences in clinical IVD disease which correlate with their physi-
cal appearance and are defined by their genetic background. In CD
dogs, NCs are replaced by CLCs around 1 year of age and back pain
due to IVD degeneration usually develops around 3 to 7 years of age.
In NCD dogs, NCs can remain the predominant cell type during life and
if low back pain develops, it occurs around 6 to 8 years of age.41
To determine the expression of possible relevant hedgehogs (ie,
IHH and SHH) and PTHrP during loss of the NC phenotype, hedgehog-
and PTHrP-related gene and protein expression was studied in healthy-
maturated canine IVDs and NCs from healthy NCD canine IVDs. To
determine the role of hedgehog and PTHrP in IVD degeneration,
F IGURE 1 Schematic setup of the study. The role of hedgehog proteins (Indian and Sonic hedgehog; IHH and SHH, respectively) and
parathyroid hormone-related protein (PTHrP) in the intervertebral disc (IVD) was determined in two different phases: during loss of the
notochordal (NC) phenotype (maturation phase) and in maturated until severely degenerated IVDs (degeneration phase). Hedgehog- and PTHrP-
related protein expression was determined using immunohistochemistry in canine and human NPs from healthy until severely degenerated IVDs,
for example, natural IVD maturation and degeneration. To further elucidate the expression of hedgehog proteins and PTHrP during loss of the NC
phenotype, IHH- and PTHrP-related gene expression was studied in NCs from healthy canine IVDs that lost their specific phenotype and marker
(brachyury, cytokeratin 8) expression during monolayer culture. To determine the role of hedgehog proteins and PTHrP in IVD degeneration, the
correlation between PTHrP and hedgehog (receptor) expression and calcification was furthermore determined in surgically removed human NP
samples across the range of histological IVD degeneration. Lastly, the effect of hedgehog proteins and PTHrP was determined on calcification of
canine and human CLCs in vitro
TABLE 1 Hedgehog, PTHrP, and related receptor expression during IVD maturation, degeneration and calcification
Hedgehog PTCH1 SMO PTHrP PTHR1
IVD maturation
IHC on canine NP tissue Not available # # ± ±
Canine NC de-differentiation #
(IHH and SHH mRNA)
± ± # #
IVD degeneration
IHC on canine NP tissue Not available "a "b " "b
IHC on human NP tissue ± " " " ±
IVD calcification
IHC on human NP tissue " ± ± ± "
Note: Hedgehog, PTHrP, and related receptor expression was studied during intervertebral disc (IVD) maturation (loss of the notochordal (NC) phenotype)
using different models as given in Figure 1. Hedgehog signaling and PTHrP-related protein expression was determined using immunohistochemistry (IHC)
in nucleus pulposus (NP) tissue from healthy (Thompson score I) until maturated (Thompson score II) canine IVDs, for example, natural IVD maturation.
Additionally, hedgehog- and PTHrP-related mRNA expression was studied in NCs from healthy canine IVDs that de-differentiated and lost their typical
vacuolated phenotype and characteristics during monolayer culture. Furthermore, hedgehog, PTHrP and related receptor expression was studied during
IVD degeneration using immunohistochemistry in NPs from maturated (Thompson score II) until severely degenerated (Thompson score V) canine and
human IVDs collected during standard postmortem diagnostics. Lastly, the correlation between IVD calcification levels and hedgehog, PTHrP and related
receptor expression was studied in surgically removed human NP tissue.
Abbreviations: CD, chondrodystrophic; NCD, non-chondrodystrophic; PTCH1, patched, PTHrP, parathyroid hormone-related protein, PTHR1, PTHrP
receptor; SMO, smoothened; ±, not significantly affected.
aOnly in NCD dogs.
bOnly in CD dogs.
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hedgehog- and PTHrP-related protein expression was studied in matu-
rated until severely degenerated canine and human IVDs. Additionally,
the correlation between hedgehog, PTHrP and related receptor expres-
sion and calcification was determined in surgically removed human NP
tissue across the range of histological IVD degeneration. Lastly, the
effect of IHH, SHH, and PTHrP was determined on calcification of
canine and human CLCs from degenerated IVDs in vitro.
2.2 | Hedgehog-PTHrP expression in cultured NC
clusters
To study hedgehog and PTHrP expression during loss of the NC pheno-
type, hedgehog, and PTHrP related gene expression was studied in NCs
from healthy NCD canine IVDs that lost their typical vacuolated pheno-
type and marker (brachyury, cytokeratin 8) expression during monolayer
culture.42 This model represents NC de-differentiation in vitro rather
than the transition towards the CLC phenotype. The cervical and
thoracolumbar IVDs were collected from eight NCD dogs (mixed breed,
13-60 months) euthanized in unrelated experiments, approved by the
Utrecht University Animal Ethics Committee. NC clusters were
obtained as described previously42 and cultured in their original cluster-
like formation. Briefly, to imitate NC de-differentiation, the NC clusters
from each donor were plated in 6-wells and cultured for 4 days at
37C, 5% CO2, 21% O2 in DMEM-F12 (10 565 018, Gibco), 10% fetal
bovine serum (FBS, 16000-044, Life Technologies) and 1% penicillin/
streptomycin (P/S, P11-010, PAA Laboratories). Samples for RT-qPCR
were collected at day 0, 2, and 4. RNA was isolated and cDNA was gen-
erated from the cultured NCs (n = 8) and native NPs (n = 6) as described
previously.42 RT-qPCR for IHH, SHH, patched (PTCH1), smoothened
(SMO), parathyroid hormone-related protein (PTHrP), parathyroid hor-
mone receptor-1 (PTHR1), and transcription factors GLI1, GLI2, and GLI3
was performed and analyzed as described previously3 (Supporting infor-
mation 1). For determination of relative quantitative gene expression,
the Normfirst (EΔΔCq) method was used. For each target gene, the Cq-
value of the test sample was normalized to the mean Cq-value of four
stably expressed reference genes (GAPDH, HPRT, RPS19, and SDHA):
ΔCq = Cq mean ref − Cq target. Secondly, the EΔCq-value for the test and
calibrator sample was calculated. In this formula, E indicates the amplifi-
cation efficiency of the target/reference gene and the mean Cq-value of
all tested samples was used as calibrator. EΔΔCq was calculated by nor-
malizing the EΔCq-value of the test sample to one of the calibrators:
EΔΔCq = EΔCq test/EΔCq calibrator. For each target gene, the relative expres-
sion and standard deviations in gene expression were calculated.
2.3 | Hedgehog-PTHrP expression in healthy until
severely degenerated canine and human NPs
Hedgehog- and PTHrP-related immunopositivity was determined in
canine and human NPs from healthy until severely degenerated
(Thompson scores I-V) IVDs. All dogs had been euthanized in unrelated
experiments, approved by the Utrecht University Animal Ethics
Committee, or were client-owned dogs that were submitted for nec-
ropsy to the Faculty of Veterinary Medicine, Utrecht University. Thirty-
seven thoracolumbar or lumbosacral IVDs from dogs of various breeds
(5 CD, 11 NCD), age (1-16 years) and gender (11 female, 5 male) were
studied (Supporting information 2). The samples were divided into five
different grades of degeneration based on gross morphology of midsag-
ittal sections (Thompson grading): score I is healthy and score V repre-
sents end-stage degeneration.43,44 IVD donors were chosen based on
equal representation of all Thompson scores (n = 8-7-8-7-7 for grades
I-V, respectively). Tissue was obtained <24 hours after death, and IVD
slices were decalcified in 0.5 M EDTA (pH 7.0) for 3 months as previ-
ously described.45 Sections were dehydrated and rinsed in xylene
before being embedded in paraffin wax.
Human IVDs were obtained during standard postmortem diag-
nostics. The L2-L5 part of the spine was collected (<48 hours after
death), as approved by the scientific committee of the Pathology
department (University Medical Centre Utrecht [UMCU]). Anonymous
use of redundant tissue for research purposes is a standard treatment
agreement with UMCU patients (Local Medical Ethical Committee
number 12-364). IVDs were used in line with the code “Proper Sec-
ondary Use of Human Tissue,” installed by the Federation of Biomedi-
cal Scientific Societies. Also, the human IVDs were chosen based on
approximately equal representation of all Thompson scores
(n = 5-4-4-5-4 for grades I-V, respectively, Supporting information 2).
IVD tissues were decalcified in Kristensen's solution (50% formic acid
and 68 g/L sodium formate) in a microwave oven at 150 W and 50C
for 6 hours as previously described.46,47 Sections were dehydrated
and rinsed in xylene before embedding in paraffin wax and after
hematoxylin and eosin (H&E) staining histologically graded.48,49
Briefly, sections were scored numerically between 0 and 12 based on
the presence of cell clusters, fissures, loss of demarcation and
hematoxophilia (indicating reduced proteoglycan content).
For both canine and human samples, 5-μm midsagittal sections
were mounted on Microscope KP+ slides (KP-3056, Klinipath) and
immunohistochemically stained for N-terminal hedgehog (IHH/SHH),
PTCH1, SMO, PTHrP, and PTHR1 (Table 2). Negative control sections
stained with blocking peptides for the specific target proteins did not
show staining. End plates of each section served as internal positive
control. Hedgehog proteins undergo intramolecular cleavage cata-
lyzed by their C-terminal domain, yielding an N-terminal product,
which represents the mature and biologically active hedgehog form
and a C-terminal product with no known signaling-related function.10
The hedgehog antibody employed in the present study most probably
recognizes both hedgehogs as the N-terminus of SHH and IHH dem-
onstrates 88% homology (pairwise alignment) up to splicing at AA
202 (IHH) or AA 198 (SHH).
For all staining, raw images were captured with a Leica DFC420C
digital camera (Leica Microsystems) mounted to a BX60 microscope
(Olympus) and Leica Application Suite (V4.2) software package.
(Positively stained) cell numbers in each NP were manually counted.
Adobe Photoshop CS6 was used to manually count (positively stained)
cell numbers in four (canine) or six (human) randomly selected NP
areas per IVD section as described previously.50 The mean percentage
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of cells that stained positive over the total number of cells present
(ratio) was determined per Thompson score for every target protein.
Immunopositivity thus indicates the ratio of positive cells, not inten-
sity of the staining. Notably, PTHrP was highly expressed only in
young canine donors with healthy (Thompson score I) IVDs and its
expression was considerably lower in older canine donors with
healthy IVDs. To further explore the effect of age on PTHrP expres-
sion, Thompson score I IVDs of younger canine and human donors
were also studied. NPs from eight canine (1 day and 6 weeks of age)
and 12 human (21 weeks of gestation and 3 months of age, postnatal)
donors were fixed in 4% neutral buffered formaldehyde, embedded in
paraffin, and 5-μm sections were stained for PTHrP as described pre-
viously (Table 2).
2.4 | Correlation between PTHrP/hedgehog
expression and calcification in human NPs
Surgically removed NP tissue (ethical approval was granted from Shef-
field Research Ethics Committee [09/H1308/70]) was fixed in 10%
v/v neutral buffered formalin and processed to paraffin wax. Follow-
ing embedding, 4-μm sections were cut and histologically graded using
the previously published criteria.48,49 To determine the frequency of
calcium deposition in the NP of human IVDs, initial work investigated
Alizarin Red S staining on 113 human NP samples with different
grades of degeneration (Supporting information 2). Calcium deposition
was then manually scored on a grade of 0 to 3, where 0 was no cal-
cium deposits present and 3 was intense calcium (Figure 5A). Histo-
logical grading was performed by two independent blinded
investigators (C.L.M. and J.S.), whereas immunohistochemistry (IHC)
was analyzed by one blinded observer (C.L.M.). To enable comparison
of low vs high calcium deposition, percentage of samples from non-
degenerate, mid-grade degenerate, and high-grade degenerate discs
were then determined for those scoring ≤1 (low) and > 1 (high) cal-
cium staining intensity. Thereafter, the correlation between PTHrP,
hedgehog and related receptor expression (ratio) and calcification
staining intensity was determined in a smaller subset of 30 surgically
removed human NP samples with different degeneration grades and
calcium deposition (Supporting information 2). N-terminal hedgehog,
PTCH1, SMO, PTHrP, and PTHR1 IHC and Alizarin Red S staining51
were performed as described previously.
2.5 | The effects of hedgehog and PTHrP on
calcification in CLC monolayers
Passage 2 CLCs from four canine donors (three Beagles [male], one
Cocker Spaniël [female], 2-6 years of age) and four human donors
(three male, one female, 50-63 years of age) were plated at a density
of 10 000 cells/well in 12-wells plates (665 180, Greiner) in expansion
medium (hgDMEM+Glutamax [31 966, Invitrogen] with 10% FBS, 1%
P/S, 0.1 mM Ascorbic acid 2-phosphate [Asap, A8960, Sigma-Aldrich],
10−9 M dexamethasone [AD1756, Sigma-Aldrich] and 1 ng/mL bFGF
[PHP105, AbD Serotec]) at 21% O2, 5% CO2, 37C. All canine and
human IVDs were mildly degenerated (Thompson grade II/III). After
1 week, expansion medium was replaced by hypertrophic induction
medium (hgDMEM+Glutamax, 1% P/S, 1% ITS+ premix, 0.1 mM Asap,
10−9 M dexamethasone, 10 mM β-glycerolphosphate [G9422, Sigma-
Aldrich], and 1 nM 3,30,5-triiodo-L-thyronine [T3, T6397, Sigma-
Aldrich])52 supplemented with/without 10−7 M PTHrP (PTH-Related
Protein [1-34] amide, H-9095, Bachem), 1 μg/mL N-terminal IHH
(1705-HH, R&D Systems) or 1 μg/mL N-terminal SHH (1845-SH,
R&D Systems). Concentrations for PTHrP,53 SHH,54 and IHH55 were
chosen based on previous research. In order to facilitate hypertrophic
CLC differentiation and calcification, CLCs from the same canine
donors were also seeded in osteogenic culture medium (consisting of
hgDMEM+Glutamax, 10% FBS, 1% P/S, 0.1 mM Asap, 10−7 M dexa-
methasone and 10 mM β-glycerolphosphate)51 supplemented with/
without 1 μg/mL IHH/SHH or 10−7 M PTHrP. After 14 days, mono-
layers were fixed in 4% neutral buffered formaldehyde for 2 hours.
Alizarin Red S staining51 was performed as described previously. On
the canine CLCs, also RT-qPCR was performed as described












ND 4 0.1% trypsin (30 min, 37C).
PTCH Santa cruz, sc-6149 4 4 Citrate buffer (10 mM, pH 6, 30 min, 70C)
SMO Santa cruz, sc-6366 4 8 Citrate buffer (10 mM, pH 6, 30 min, 70C)
PTHrP Santa cruz, sc-9680 4 8 Citrate buffer (10 mM, pH 6, 30 min, 70C)
PTHR1 Santa cruz, sc-12 777 10 10 Citrate buffer (10 mM, pH 6, 30 min, 70C)
Note: For all Santa Cruz antibodies the ImmunoCruz goat LSAB Staining System (sc-2053, Santa Cruz) with was used. For N-terminal hedgehog expression,
EnVision+ System-HRP Goat Anti-Rabbit (DAKO, K4003) secondary antibody and 5% BSA/PBS (30 min) blocking was used.
Abbreviations: ND, not done, lack of reactivity to canine samples; PTCH, patched, PTHrP, parathyroid hormone-related protein, PTHR1, PTHrP receptor;
SMO, smoothened.
aDetects both N-terminal IHH and SHH.
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previously3 for PTHR1, RUNX2, and ALP (Supporting information 1).
Due to limited availability, this was not possible for human CLCs.
2.6 | Statistical analysis
Statistical analysis was performed using IBM SPSS (version 22). All data
were examined for normal distribution (Shapiro-Wilks test). Kruskal-Wallis
and Mann-Whitney U tests were performed on nonnormally distributed
data, whereas general linear regression models based on ANOVAs were
used for normally distributed data. To find correlations between protein
immunopositivity and IVD degeneration score, partial correlations
(corrected for donor) were determined. Benjamini & Hochberg False Dis-
covery Rate post-hoc corrections for multiple comparisons were per-
formed. A P-value <.05 was considered significant. A χ² test was
performed to determine whether calcium deposition (≤1 and > 1 inten-
sity) increased per histologic degeneration grade (≤4, 4.1-7, and > 7).
3 | RESULTS
3.1 | Expression of hedgehog proteins and PTHrP
during IVD maturation
To study the IVD maturation phase (defined by loss of the NC pheno-
type), hedgehog and PTHrP signaling-related expression was studied
in vitro in NCD canine NC-rich NP tissue and 0 to 4 day cultured NC
clusters described to de-differentiate and lose their specific pheno-
type and marker (brachyury, cytokeratin 8) expression by gene expres-
sion analysis42 and by immunohistochemistry of the NP.
F IGURE 2 Hedgehog and PTHrP signaling-related mRNA expression in canine nucleus pulposus (NP) tissue and cultured notochordal cell
(NC) clusters. The NC clusters de-differentiate, that is, lose their typical vacuolated phenotype and characteristics (eg, brachyury and cytokeratin
8 mRNA expression) during 4-day monolayer culture. mRNA expression of both the hedgehog and PTHrP signaling pathway decreases with NC
de-differentiation. IHH, Indian hedgehog; NCD, non-chondrodystrophic; n.s., not significant; PTCH1, patched, PTHrP, parathyroid hormone-
related protein, PTHR1, PTHrP receptor; SHH, Sonic hedgehog; SMO, smoothened. n = 6 (NP tissue) - 8 (NC clusters). T0, T2, T4: NC clusters at
culture day 0, 2, and 4, respectively. *P < .05 and **P < .01
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3.1.1 | Gene expression of canine NC cluster
culture
IHH messenger RNA (mRNA) expression was significantly higher in NCD
canine NP tissue than in 0- to 4-day cultured NCs (P < 0.05), where it
was hardly detectable (Figure 2A). SHH mRNA expression was signifi-
cantly higher in non-cultured NCs (culture day 0) and decreased rapidly
during culture (P < .05, Figure 2B). PTCH1 mRNA expression was signifi-
cantly lower in NCD NP tissue than in 0- to4-day cultured NCs (P < .01,
Figure 2C). SMO mRNA expression decreased from day 0 until day 2 and
thereafter increased again, and was significantly higher in 4-day cultured
NCs than in NCD NP tissue (P < .05, Figure 2G). mRNA of transcription
factor GLI1, target gene of hedgehog signaling, was hardly detectable at
T0 and T2, and was not differentially expressed between groups
(Figure 2D). GLI2 mRNA was expressed at significantly higher levels in
NCD NP tissue than in 0- to 4-day cultured NCs (P < .01), where it was
hardly detectable (Figure 2E). mRNA expression of GLI3 was significantly
lower in NCD NP tissue than in 0- to -4 -day cultured NCs (P < .05,
Figure 2F). Taken together, although PTCH1 and SMO mRNA was
expressed, mRNA of IHH, SHH (both hedgehog ligands) and their tran-
scription factors GLI1 and GLI2 was hardly detectable (Cq-values > 35) in
canine NCs that lost their typical vacuolated morphology during culture.
PTHrP mRNA expression was significantly higher in freshly iso-
lated NCs than in native tissue (P < .05) and decreased rapidly during
NC culture (P < .05, Figure 2H). Also, PTHR1 mRNA expression
decreased from day 0 to days 2 and 4 in culture (P < .01, Figure 2I).
Furthermore, it was significantly lower in 2- and 4-day cultured NCs
than in NCD NP tissue (P < .05).
3.1.2 | Histology of canine and human IVD
maturation and degeneration
In healthy, Thompson score I canine NPs, only NC clusters were
detected (Figure 3E). In maturated, Thompson score II canine NPs,
mainly CLCs were present; only one NCD canine NP also contained
some NCs. In Thompson scores III to V canine NPs, only CLCs were
encountered in single cells and clusters. In NPs from healthy, Thomp-
son score I human IVDs, mainly CLCs and only some NCs were
detected, mainly as single cells, but also in clusters (Figure 4G). In NPs
from Thompson scores II to V human IVDs, only CLCs were encoun-
tered in single cells and clusters. In both species, CLC clusters were
more abundant and larger in NPs from Thompson score IV and V
IVDs. Immunopositivity, regardless of the proteins and species, was
identified in both single cells and clusters without an evident spatial
distribution pattern in both species.
3.1.3 | Hedgehog signaling and PTHrP
immunopositivity in canine IVD maturation
The N-terminal hedgehog antibody demonstrating active hedgehog
(IHH, SHH) signaling did not render specific staining in the canine
samples and therefore, this antibody was only studied in human tis-
sues. Immunopositivity (ratio of positive cells) for PTCH1 and SMO
was significantly higher in canine NP tissues from healthy, Thompson
score I NC-rich IVDs than in NP tissue from maturated, Thompson
score II CLC-rich IVDs (P < .05, Figure 3A,B), suggesting higher
expression in NCs than CLCs. PTHrP and PTHR1 immunopositivity
did not differ between NPs from healthy and maturated canine IVDs
(Figure 3C,D). Notably, PTHrP immunopositivity in healthy canine
IVDs seemed to depend on age: PTHrP was detected in more than
10% of the NCs of 7- and 16-month-old canine donors, whereas this
was 0% to 5% in older (17- until 96-month-old) canine donors
(Figure 3C,E). This indicates that PTHrP was present in NCs from
young, healthy canine IVDs, but that its expression decreased during
aging (in contrast to the expression of PTHR1, PTCH1, and SMO). To
confirm this, Thompson score I IVDs of younger canines (1 day and
6 weeks of age) were also investigated together with human
(21 weeks of gestation and 3 months of age) donors as comparators.
These canine NPs contained approximately 100% NCs, mainly present
in clusters (Supporting information 3). In contrast, the human NPs also
contained, smaller fibroblast- and chondrocyte-like cells in clusters
and single cells, in addition to the typical NCs (Supporting information
3). All young canine NPs showed abundant PTHrP immunopositivity
in their NCs, with no clear pattern in spatial distribution. In contrast,
only seven out of 12 NPs from young human donors showed PTHrP
immunopositivity in both NC and CLC clusters and single cells
(no spatial distribution; Supporting information 3). Taken together,
this indicates that PTHrP expression is present in young, healthy NPs,
but that its expression considerably decreases in older, healthy NPs,
in line with results obtained using equine chondrocytes.56
Taken together, the mRNA expression pattern of both hedgehog
and PTHrP-signaling related genes in de-differentiated NCs (Figure 2)
were confirmed by the protein expression pattern of maturing canine
IVDs (Figure 3), that is, reduced mRNA levels and immunopositivity
coincided with the loss of the NC phenotype.
3.2 | Hedgehog and PTHrP in canine and human
degenerating IVDs
Regardless the species, hedgehog and PTHrP staining was cytoplas-
mic, while for PTCH1, SMO, and PTHR1, both the cell membrane and
the cytoplasm demonstrated immunopositivity (Figures 3E and 4G).
The latter seems to be counterintuitive considering the fact that
PTCH1, SMO, and PTHR1 are transmembrane proteins. Nonetheless,
cytoplasmic immunopositivity can be well explained for all these three
proteins. Hedgehog ligands bind to their transmembrane receptor
PTCH1 and cause PTCH1 inactivation, internationalization, and fur-
ther degradation. Inhibition of PTCH1 is followed by SMO activation
(located intracellularly) and translocation to the cell membrane, which
initiates the canonical hedgehog signal transduction.57 As such,
dependent on its localization, different forms of PTCH1 can be distin-
guished: (a) unliganded PTCH1, which is active and localized to the
cell membrane and (b) PTCH1 bound to the ligand that is further
BACH ET AL. 7 of 15
F IGURE 3 Hedgehog and PTHrP signaling-related immunopositivity in canine intervertebral discs with different degeneration grades. Both
signaling pathways are activated in healthy IVDs and increase with degeneration. The N-terminal hedgehog antibody demonstrating active
hedgehog signaling did not render specific staining in the canine samples and was therefore not included. CD, chondrodystrophic; NCD, non-
chondrodystrophic; PTCH1, patched; PTHrP, parathyroid hormone-related protein, PTHR1, PTHrP receptor 1; SMO, smoothened. n = 7-8 per
Thompson score. *P < .05, **P < .01 and ***P < .001
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internalized and may be further degraded.58 Internalization of PTCH1
is postulated to also contribute to modulation of hedgehog signaling,
which remains to be further resolved. The epitope of the PTHR1 anti-
body maps near the N-terminus which has been demonstrated to
remain associated with its ligand within endosomes, challenging the
classical paradigm of G protein-coupled receptor signaling.59 Consid-
ering the semi-quantitative nature of immunostainings and technical
challenges concerning quantification, follow-up analysis of
immunostainings did not distinguish between the different patterns of
immunopositivity.
3.2.1 | Degenerating canine IVDs
Considering the differential clinical representation of IVD disease
among dog breeds,41 the canine IVDs were separately analyzed for
CD and NCD dogs. PTCH1 immunopositivity, a direct target of active
hedgehog signaling, was significantly higher in NPs from Thompson
scores IV to V canine IVDs than in NPs from Thompson score II to III
IVDs (P < .05, Figure 3A). Only NCD dogs showed a positive correla-
tion between PTCH1 immunopositivity and macroscopic IVD degen-
eration grade (Thompson scores II-V, P < .05, r:0.552), whereas only
CD dogs showed a positive correlation between SMO
immunopositivity and macroscopic IVD degeneration grade (P < .05,
r:0.621). PTHrP immunopositivity significantly increased during canine
IVD degeneration (P < .01, Figure 3C). In both CD and NCD dogs, a
positive correlation between PTHrP immunopositivity and macro-
scopic IVD degeneration grade was observed (P < .05, r:0.627
[CD] and P < .01, r:0.748 [NCD]). Immunopositivity for PTHR1
increased from NPs of maturated, Thompson scores II to III IVDs to
severely degenerated, Thompson score V IVDs (P < .05, Figure 3D).
Only CD dogs showed a positive correlation between PTHR1
immunopositivity and macroscopic IVD degeneration grade (P < .01,
r:0.696). Although the current study demonstrates some differences
in hedgehog-PTHrP (related) expression between CD and NCD dogs,
which may be related with their differential genetic background, the
direction of the correlation between protein expression and IVD
degeneration grade was similar.
3.2.2 | Human degenerating IVDs
As expected, a strong, positive correlation was found between the
macroscopic Thompson and the histologic IVD degeneration
score48,49 of the human samples collected postmortem (r:0.907,
P < .001; Figure 4F). To be able to relate these results to the follow-
up analysis (ie, the relationship between PTHrP/hedgehog
immunopositivity and calcification in surgically removed human NP
samples), correlation are given in relation to the histological IVD
degeneration grade. A significant positive correlation between
PTCH1, SMO, and PTHrP immunopositivity and histologic IVD degen-
eration grade was encountered (P < .05, r:0.679, 0.577, 0.502, and
0.848, respectively; Figure 4B-D). There was, however, no significant
correlation between N-terminal hedgehog or PTHR1
immunopositivity and histologic IVD degeneration grade
(Figure 4A, E).
3.3 | Hedgehog and PTHrP in IVD calcification
To further explore the role of hedgehog and PTHrP in more clinically
relevant material, immunopositivity was correlated to calcification in
surgically removed human NP samples across the range of histological
IVD degeneration.48,49 Lastly, the effect of IHH and SHH was deter-
mined on calcification of canine and human CLCs in vitro. Initial exper-
iments in canine CLCs (n = 4 Beagles) demonstrated that PTHrP did
not induce calcifications under the conditions studied (Supporting
information 5) and was further disregarded for follow-up culture
experiments.
The morphological assessment of the calcium staining intensity
was divided into two groups (≤1 and > 1 staining intensity;
Figure 5A). The percentage of human NP tissue samples with high
calcium deposition significantly increased with the histologic IVD
degeneration grade (Figure 5B; P < .05). Moreover, the number of
cells with PTHR1 and N-terminal hedgehog immunopositivity was
significantly higher in the NP tissues associated with high calcium
deposition (P < .01; Figure 5C,D). In contrast, no difference in num-
ber of immunopositive cells for PTHrP (Figure 5C,D), PTCH1 and
SMO (data not shown) was observed between the NPs with low or
high calcium deposition.
Short-term CLC monolayer culture has previously been employed
as a model to study calcium deposition.37,60 Interestingly, the canine
CLCs seeded in osteogenic culture medium did not thrive; they failed
to attach to culture plastic and died within 24 hours. Canine CLCs
treated with hypertrophic induction medium + SHH demonstrated
increased gene expression of (pre)hypertrophic differentiation
markers PTHR1, RUNX2, and ALP compared with hypertrophic induc-
tion medium alone and hypertrophic induction medium + IHH
(Figure 6A). Affirmatively, hypertrophic induction medium alone
induced calcification in canine and human CLC monolayers, while the
supplementation of SHH exerted a more pronounced effect in this
respect compared to IHH (Figure 6B,C and Supporting information 4).
F IGURE 4 Hedgehog and PTHrP signaling-related immunopositivity in human intervertebral discs with different degeneration grades. The
samples were graded according to the macroscopic Thompson score and histologic degeneration score, which strongly correlated with each
other. Both signaling pathways are increasingly activated with progress of degeneration. Hedgehog: N-terminal active hedgehog expression,
PTCH1, patched, PTHrP, parathyroid hormone-related protein, PTHR1, PTHrP receptor 1; SMO, smoothened. n = 4-5 per Thompson score.
*P < .05 and ***P < .001
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4 | DISCUSSION
Treatment strategies leading to functional IVD restoration can benefit
from in-depth knowledge of the pathways involved in IVD degeneration.
Therefore, this study focused on the largely unexplored role of PTHrP
and hedgehog proteins in the postnatal IVD of species that can suffer
from clinical IVD disease. The current manuscript provides the first step
towards a better understanding of the possible involvement of PTHrP
and hedgehog proteins in IVD maturation, degeneration, and calcification.
4.1 | Hedgehog and PTHrP expression decreases
during IVD maturation
To study hedgehog- and PTHrP-related mRNA and protein expression
during loss of the NC phenotype, NC-rich healthy and CLC-rich matu-
rated canine IVDs as well as canine NCs that de-differentiated during
monolayer culture7 were studied. The results from those two models
indicate that the expression of SHH/IHH, PTHrP and their receptors
was high in healthy, NC-containing NPs, but decreased with the
F IGURE 6 Indian and Sonic hedgehog facilitate calcification in human and canine chondrocyte-like cells in vitro. (A) Hedgehog and PTHrP
signaling-related mRNA expression in canine CLC monolayers treated with hypertrophic induction medium supplemented with/without 1 μg/mL
IHH or SHH for 7 days. n = 4. **P < .01. ALP, alkaline phosphatase; IHH, Indian hedgehog; PTHR1, PTHrP receptor 1, RUNX2, Runt-related
transcription factor 2; SHH, Sonic hedgehog. Alizarin Red S staining on one representative canine (B) and human (C) CLC donor. CLC monolayers
were treated with hypertrophic induction medium supplemented with/without 1 μg/mL IHH or SHH for 7 days. n = 4 per species
F IGURE 5 PTHrP, PTHR1, and N-terminal hedgehog immunopositivity and calcium deposition in surgically removed human nucleus pulposus
tissue across the range of histological IVD degeneration. The degree of histologic IVD degeneration was divided into three groups (≤4, 4.1-7,
and > 7), while calcium deposition was divided into low (≤1) and high (≥1) intensity. (A) Alizarin Red S staining of representative samples with
different calcium staining intensity (0-3). (B) Calcium deposition increases with the degree of histologic IVD degeneration. n = 133 (C) PTHrP,
PTHR1, and N-terminal hedgehog immunopositivity (ratio) vs calcium deposition (low (≤1) and high (≥1) intensity). Bars indicate median. n = 30
(D) Alizarin Red S staining (AR; left) and immunohistochemistry (IHC; right) for PTHrP, PTHR1, and N-terminal hedgehog of representative human
NP samples with low (≤1) and high (≥1) calcium deposition. Hedgehog: N-terminal active hedgehog expression, PTHrP, parathyroid hormone-
related protein, PTHR1, PTHrP receptor 1, **P < .01
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transition towards maturated, CLC-containing NPs. Whether the
observed changes in expression are a cause or consequence of the
maturation process; play a role in preservation of NCs; or are related
to NP differentiation, remains to be determined with the aid of antag-
onists or functional knock-out/in models.
4.2 | Hedgehog and PTHrP expression increases
from maturated towards severely degenerated IVDs
PTCH1, SMO (both direct targets of active hedgehog signaling) and
PTHrP expression increased during the IVD degeneration process in
the studied species. This result is in line with the positive correlation
between IHH expression and OA,22–25 a process resembling IVD
degeneration.32 PTHR1 immunopositivity increased from maturated
to severely degenerated canine, but not human IVDs. While a species-
specific difference cannot be excluded, the different decalcification
procedures of the IVD segments may have affected the results.61 This
plausible explanation is further underscored by the observation that
non-decalcified human NP samples collected during surgery demon-
strated increased PTHR1 immunopositivity in direct relation to cal-
cium deposition levels seen in higher frequencies in degenerated NPs.
Altogether, the descriptive results from the present study indicate
that activated hedgehog and PTHrP signaling are involved in IVD
degeneration. Therefore, functional in vitro studies were performed
to explore the role of PTHrP and hedgehogs in degenerated IVDs.
4.3 | Calcium levels increase in the human NP
during IVD degeneration
Based on their well-described role in chondrocytes,22–24,30 hedgehog
proteins and PTHrP could be involved in hypertrophic CLC differenti-
ation and calcification, processes that are known to occur during the
later stages of IVD degeneration.32,62–64 The present study confirmed
a positive correlation between human NP calcification levels and IVD
degeneration grade. A significant, positive correlation between N-
terminal hedgehog immunopositivity and calcification was detected in
human NP tissue collected during therapeutic surgical procedures. In
line with this, previous work displayed a significant association
between IHH and calcification in OA samples.22–24 PTHR1
immunopositivity was also significantly higher in NPs with abundant
calcification vs those with no/low calcification, which can be
explained by the cellular phenotype: PTHR1 is mainly expressed in
prehypertrophic cells65 and calcium is most likely deposited in
severely degenerated IVDs32,62,63 with (pre)hypertrophically differen-
tiated CLCs. Previous work showed that PTH inhibits terminal differ-
entiation of chondrocytes31 and calcification in CLCs37 and that
PTHrP inhibits calcification in chondrocytes.30 In contrast, in the pre-
sent study, PTHrP immunopositivity was similar between NPs with
low or abundant calcification and PTHrP did not affect calcification of
CLCs in vitro. However, assuming that PTHrP inhibits the IVD calcifi-
cation process in vivo, the absence of PTHrP upregulation in later
stages of degeneration even in the presence of high PTHR1 levels
may allow for NP calcification in the process of degeneration.
4.4 | SHH and IHH induce calcification in canine
and human CLCs
In contrast to PTHrP, IHH is known to promote chondrocyte hyper-
trophy and calcification in OA.22–24 To the best of our knowledge, this
is the first study to demonstrate that IHH and especially SHH also
have the propensity to induce calcification in human and canine CLCs
from degenerated IVDs in vitro. Interestingly, SHH was even more
potent in inducing calcification in human and canine CLCs than IHH.
Together with the increased hedgehog expression in IVDs with high
levels of calcium, this may suggest a possible role for SHH and/or IHH
in calcification during IVD degeneration. In line with this thought,
disrupted IHH signaling prevented hypertrophic chondrocyte differen-
tiation and osteophyte formation in OA cartilage.26,27 Possibly, this
could also be a therapeutic approach to prevent or retard these pro-
cesses during IVD degeneration. From a clinical perspective, however,
additional considerations need to be acknowledged, including possible
side effects of inhibited hedgehog signaling, for example, on the car-
diovascular66 and central nervous67 system.
5 | CONCLUSIONS
Expression of hedgehogs, PTHrP and their receptors were high in NCs
from young, healthy IVDs, decreased together with the loss of the NC
phenotype, and increased again in the advanced stages of IVD degen-
eration. While PTHrP did not affect calcification, IHH and mainly SHH
had the propensity to facilitate calcification in human and canine CLCs
in vitro. Taken together with the increased N-terminal hedgehog
immunopositivity in IVDs with high levels of calcium deposition, this
may indicate that inhibition of hedgehog signaling could be a thera-
peutic approach to inhibit CLC calcification in IVD degeneration.
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